Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis

BACKGROUND: The efficacy of neoadjuvant chemotherapy for advanced gastric cancer is not yet firmly confirmed, but the exciting results demonstrated in several clinical studies have led neoadjuvant chemotherapy as the important treatment methods in guidelines. The 4–6 weeks interval time is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yuhao, Zheng, Zhi, Deng, Wei, Yin, Jie, Bai, Zhigang, Liu, Xiaoye, Zhang, Jun, Zhang, Zhongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885804/
https://www.ncbi.nlm.nih.gov/pubmed/36726960
http://dx.doi.org/10.3389/fsurg.2022.1047456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885804/
https://www.ncbi.nlm.nih.gov/pubmed/36726960
http://dx.doi.org/10.3389/fsurg.2022.1047456

Ejemplares similares